Royal Bank of Canada decreased its holdings in Global Medical REIT Inc. (NYSE:GMRE - Get Rating) by 0.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,233,333 shares of the company's stock after selling 10,916 shares during the period. Royal Bank of Canada owned about 1.88% of Global Medical REIT worth $10,507,000 as of its most recent SEC filing.
→ The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (From Investing Trends)
A number of other large investors also recently made changes to their positions in the business. Tudor Investment Corp Et Al grew its stake in shares of Global Medical REIT by 124.2% in the 3rd quarter. Tudor Investment Corp Et Al now owns 163,620 shares of the company's stock valued at $1,394,000 after buying an additional 90,656 shares in the last quarter. Boothbay Fund Management LLC bought a new stake in shares of Global Medical REIT in the 3rd quarter valued at approximately $204,000. Penserra Capital Management LLC grew its stake in shares of Global Medical REIT by 10.8% in the 3rd quarter. Penserra Capital Management LLC now owns 25,670 shares of the company's stock valued at $218,000 after buying an additional 2,500 shares in the last quarter. Nuveen Asset Management LLC grew its stake in shares of Global Medical REIT by 11.6% in the 3rd quarter. Nuveen Asset Management LLC now owns 1,784,342 shares of the company's stock valued at $15,202,000 after buying an additional 185,042 shares in the last quarter. Finally, MetLife Investment Management LLC grew its stake in shares of Global Medical REIT by 9.7% in the 3rd quarter. MetLife Investment Management LLC now owns 32,044 shares of the company's stock valued at $273,000 after buying an additional 2,834 shares in the last quarter. Institutional investors and hedge funds own 65.08% of the company's stock.
Separately, B. Riley decreased their target price on Global Medical REIT from $14.00 to $12.00 and set a "buy" rating for the company in a research report on Monday. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $14.50.
Shares of Global Medical REIT stock opened at $9.65 on Friday. The stock has a market capitalization of $632.36 million, a P/E ratio of 48.25, a PEG ratio of 1.35 and a beta of 1.05. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 1.12. The stock has a 50 day moving average price of $10.43 and a two-hundred day moving average price of $9.80. Global Medical REIT Inc. has a 12-month low of $7.01 and a 12-month high of $16.47.
Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.
Want to see what other hedge funds are holding GMRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Global Medical REIT Inc. (NYSE:GMRE - Get Rating).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.